These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21983155)

  • 1. Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.
    Lorenzo ME; Hodgson A; Robinson DP; Kaplan JB; Pekosz A; Klein SL
    Vaccine; 2011 Nov; 29(49):9246-55. PubMed ID: 21983155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.
    Straight TM; Ottolini MG; Prince GA; Eichelberger MC
    Virol J; 2008 Mar; 5():44. PubMed ID: 18355405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.
    Furuya Y; Chan J; Regner M; Lobigs M; Koskinen A; Kok T; Manavis J; Li P; Müllbacher A; Alsharifi M
    J Virol; 2010 May; 84(9):4212-21. PubMed ID: 20164231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
    Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
    Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
    Quan FS; Kim MC; Lee BJ; Song JM; Compans RW; Kang SM
    Virology; 2012 Sep; 430(2):127-35. PubMed ID: 22658901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge.
    Herbert AS; Heffron L; Sundick R; Roberts PC
    Virol J; 2009 Apr; 6():42. PubMed ID: 19393093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
    Bhide Y; Dong W; Gribonika I; Voshart D; Meijerhof T; de Vries-Idema J; Norley S; Guilfoyle K; Skeldon S; Engelhardt OG; Boon L; Christensen D; Lycke N; Huckriede A
    Front Immunol; 2019; 10():646. PubMed ID: 30984200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
    Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine.
    Qiu C; Huang Y; Wang Q; Tian D; Zhang W; Hu Y; Yuan Z; Zhang X; Xu J
    Clin Infect Dis; 2012 Jan; 54(1):17-24. PubMed ID: 22052887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
    Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS
    Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
    Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
    Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.
    Choi A; Ibañez LI; Strohmeier S; Krammer F; García-Sastre A; Schotsaert M
    Front Immunol; 2020; 11():1166. PubMed ID: 32582220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.
    Hillaire MLB; van Trierum SE; Kreijtz JHCM; Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Fouchier RAM; Kuiken T; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2011 Oct; 92(Pt 10):2339-2349. PubMed ID: 21653752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
    Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
    Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice.
    Živković I; Bufan B; Petrušić V; Minić R; Arsenović-Ranin N; Petrović R; Leposavić G
    Vaccine; 2015 Oct; 33(42):5546-5552. PubMed ID: 26382601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure with influenza A virus A/WSN/1933(H1N1) resulted in viral shedding reduction from pigs challenged with either swine H1N1 or H3N2 virus.
    Wang Z; Yu J; Thomas M; Sreenivasan CC; Hause BM; Wang D; Francis DH; Kaushik RS; Li F
    Vet Microbiol; 2019 Jan; 228():26-31. PubMed ID: 30593376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.